UBS Group AG

Holdings History for BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Symbol: BCAB on Nasdaq
Investment type: Equity / Common Stocks, par value $0,0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$128,188	225,684	+138,941	+160%	$0.57	Q4 2025
30 Sep 2025	0%	+0%	$59,680	86,743	+57,168	+193%	$0.69	Q3 2025
30 Jun 2025	0%	-0%	$11,712	29,575	-18,788	-39%	$0.40	Q2 2025
31 Mar 2025	0%	0%	$16,782	48,363	-2,497		$0.35	Q1 2025
31 Dec 2024	0%	+0%	$30,058	50,860	+39,908	+364%	$0.59	Q4 2024
30 Sep 2024	0%	-0%	$19,276	10,952	-17,471	-61%	$1.76	Q3 2024
30 Jun 2024	0%	-0%	$38,940	28,423	-18,904	-40%	$1.37	Q2 2024
31 Mar 2024	0%	-0%	$162,805	47,327	-464	-0.97%	$3.44	Q1 2024
31 Dec 2023	0%	+0%	$117,566	47,791	+25,173	+111%	$2.46	Q4 2023
30 Sep 2023	0%	-0%	$38,451	22,618	-1,977	-8%	$1.70	Q3 2023
30 Jun 2023	0%	+0%	$73,785	24,595	+24,595	NEW	$3.00	Q2 2023
31 Mar 2023		-0%	$0	0	-3,071	-100%	$0.18	Q1 2023
31 Dec 2022	0%	-0%	$25,336	3,071	-2,513	-45%	$8.25	Q4 2022
30 Sep 2022	0%	+0%	$43,000	5,584	+5,584	NEW	$7.70	Q3 2022
31 Mar 2022		-0%	$0	0	-70,994	-100%	$0.18	Q1 2022
31 Dec 2021	0%	+0%	$1,393,000	70,994	+31,441	+79%	$19.62	Q4 2021
30 Sep 2021	0%	+0%	$1,164,000	39,553	+37,289	+1647%	$29.43	Q3 2021
30 Jun 2021	0%	-0%	$96,000	2,264	-264	-10%	$42.40	Q2 2021
31 Mar 2021	0%	+0%	$129,000	2,528	+2,022	+400%	$51.03	Q1 2021
31 Dec 2020	0%	+0%	$17,000	506	+506	NEW	$33.60	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.